3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Non-small Cell Lung Cancer Metastatic
1
Interventions
Specimen Handling
69
Magnetic Resonance Spectroscopy
52
Biopsy
42
Carboplatin
25
pembrolizumab
23
Radiation
23
Cyclophosphamide
23
Radiotherapy
22
Cisplatin
20
Paclitaxel
19
Nivolumab
19
Etoposide
18
olaparib
17
Doxorubicin
17
X-Rays
16
Vincristine
16
Immunoglobulin G
15
Disulfides
15
Taxes
14
Leucovorin
14
Dexamethasone
14
Cytarabine
14
Prednisone
13
Platinum
13
Bevacizumab
13
1,2-diaminocyclohexaneplatinum II citrate
13
durvalumab
12
Radiotherapy, Intensity-Modulated
12
Methotrexate
11
Ipilimumab
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
tusamitamab ravtansine
×
30 days
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts